ArticleHealth affairs scholar2025
Prevalence and trends in cannabis use disorder and cannabis poisoning among Medicaid enrollees: a multistate analysis, 2011-2022.
Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cannabis use in the United States is increasing. However, the prevalence and trends in cannabis use disorder (CUD) and cannabis poisoning among Medicaid enrollees, a vulnerable population, are not evident. Methods: Using the Merative MarketScan Multistate Medicaid Claims and Encounters Database from 2011-2022, we examined adjusted prevalence and trends in CUD and cannabis poisoning among Medicaid enrollees and by age, sex, and insurance type (managed care [MC]/fee-for-service [FFS]). Results: During the 2011 quarter (Q) 1-2022 Q4, the CUD rate increased from 336.54 to 548.96 per 100 000 enrollees per quarter-a 1.63-fold increase; the cannabis poisoning rate increased from 1.45 to 7.04 per 100 000 enrollees per quarter-a 4.86-fold increase. CUD rates were highest among those aged 18-34 years, while cannabis poisoning rates among those aged 0-17 years surpassed the rate of those aged 18-34 years by 2020 Q3. CUD and cannabis poisoning rates increased among both males and females and among those with FFS and MC, although females and MC enrollees experienced higher increases than males and FFS enrollees, respectively. Conclusion: CUD and cannabis poisoning rates among Medicaid enrollees increased significantly during 2011-2022, especially among older adults, females, and MC enrollees. Targeted education campaigns on safe use and storage of cannabis may help reduce increasing trends in CUD and cannabis poisonings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.